Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company National Institutes of Health
DescriptionLive-attenuated tetravalent dengue vaccine
Molecular Target
Mechanism of Action 
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase III
Standard IndicationDengue fever
Indication DetailsPrevent dengue fever
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today